CERENOME, INC.
Public companyAs of Nov 15, 2026, the newest executive change on record for CERENOME, INC. is the appointment of Ronald A. Andrews as Chief Business Officer, in an SEC 8-K filed Nov 12, 2026.Updated
- Headquarters
- HOUSTON, Texas
- Ticker
- CNSY
- CIK
- 0001095981
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Chief Business OfficerRonald A. Andrews | Nov 12, 2026 | Appointed |
| COOEric Daniels, M.D. | Nov 12, 2026 | Appointed |
Related companies
Same industry, the same state first.
- FILANA THERAPEUTICS, INC.
Class I director appointed: Jill M. Quigley
- GeoVax Labs, Inc.
director appointed: Shahin Behroyan
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Merck & Co., Inc.
WARN notice: Rahway, NJ
- NOVO NORDISK A S
WARN notice: Plainsboro, NJ
- Executive appointment
Chief Business Officer appointed: Ronald A. Andrews
Ronald A. Andrews was named Chief Business Officer of CERENOME, INC., effective November 9, 2026. The company reported the change in an 8-K that cites Item 5.02.
Role: Chief Business Officer
- Executive appointment
COO appointed: Eric Daniels, M.D.
Eric Daniels, M.D. was named Chief Operating Officer of CERENOME, INC., effective November 6, 2026. The company reported the change in an 8-K that cites Item 5.02.
Role: Chief Operating Officer
Last verified Nov 12, 2026
Questions about CERENOME, INC.
- Did CERENOME, INC. change its Chief Business Officer?
- Yes. Ronald A. Andrews was appointed Chief Business Officer of CERENOME, INC., reported in an SEC 8-K filed Nov 12, 2026. It is the newest executive change on record for CERENOME, INC. as of Nov 15, 2026.The SEC 8-K filingAll leadership changes